Protocol Modifications Influence the result of EGF receptor immunodetection by EGFR pharmDx in Paraffin-Embedded Cancer Tissues
Author(s): Derecskei Katalin, Moldvay Judit, Bogos Krisztina, Timar Jozef
Publication: Pathol Oncol Res, 2006, Vol. 12, Page 243
PubMed ID: 17189989 PubMed Review Paper? No
Purpose of Paper
Conclusion of Paper
Studies
-
Study Purpose
The aim of this study was to complete a comparative analysis of appropriate EGFR immunostaining of lung carcinoma specimens after incubation with the primary antibody for 30 min at room temperature or overnight at 4 degrees C.
Summary of Findings:
Results using the EGFR pharmDx kit and protocols yielded seven EGFR immuno-negative cases of the fifty examined. Extended incubation with the primary antibody overnight at 4 degrees C increased both the number of positively stained cells as well as the number of immuno-positive cases (42 vs 46).
Biospecimens
Preservative Types
- Formalin
Diagnoses:
- Neoplastic - Carcinoma
Platform:
Analyte Technology Platform Protein Immunohistochemistry Pre-analytical Factors:
Classification Pre-analytical Factor Value(s) Analyte Extraction and Purification Incubation duration/condition Overnight at 4 degrees C
30 min at room temperature
-
Study Purpose
Comparative analysis of appropriate EGFR immunostaining using the FDA approved detection method (dextran polymer conjugate) with an alternative detection method using the LSAB kit.
Summary of Findings:
EGFR immunostaining was unaffected by the alternative method of detection (LSAB kit) in comparison to the FDA approved detection method (dextran polymer conjugate).
Biospecimens
Preservative Types
- Formalin
Diagnoses:
- Neoplastic - Carcinoma
Platform:
Analyte Technology Platform Protein Immunohistochemistry Pre-analytical Factors:
Classification Pre-analytical Factor Value(s) Immunohistochemistry Specific Detection method Dextran polymer conjugate
LSAB kit
-
Study Purpose
The purpose of this study was to conduct a comparative analysis of appropriate EGFR immunostaining of lung carcinoma specimens using the FDA approved antigen retrieval technique for EGFR detection (proteinase K treatment) and the alternative method of microwave heating in citrate buffer.
Summary of Findings:
Microwave heating in citrate buffer resulted in an increase in the percentage of EGFR positively stained cells when used in combination with prolonged primary antibody incubation when compared to room temperature proteinase K digestion and a 30 min primary antibody incubation (> 50% versus <10%, respectively).
Biospecimens
Preservative Types
- Formalin
Diagnoses:
- Neoplastic - Carcinoma
Platform:
Analyte Technology Platform Protein Immunohistochemistry Pre-analytical Factors:
Classification Pre-analytical Factor Value(s) Analyte Extraction and Purification Temperature of heat-induced retrieval Room temperature
Microwave heating
Analyte Extraction and Purification Incubation duration/condition 30 min at room temperature
Overnight at 4 degrees C
Analyte Extraction and Purification Antigen retrieval 0.05M citrate buffer
0.1% proteinase K digestion